Document Detail

The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts.
MedLine Citation:
PMID:  22341039     Owner:  NLM     Status:  Publisher    
BACKGROUND: Nonstandardized allergen extracts have been used for a century. Until 1972, these products were regulated by the National Institutes of Health, and products were not required to have an individualized showing of effectiveness. Jurisdiction was then transferred to the US Food and Drug Administration (FDA), which established external review panels to make recommendations regarding safety and effectiveness. Two external panels deliberated, the first from 1974-1979 and the second from 1982-1983. OBJECTIVE: We sought to review external panels' recommendations and assess the safety and effectiveness of nonstandardized allergen extracts, FDA-reviewed available literature, and databases since 1972. METHODS: Currently licensed nonstandardized allergen extracts were reviewed according to extract type. Available data were collected from medical and nonscientific search engines. Nomenclature was ascertained by consulting or The FDA's Adverse Event Reporting System was probed for events associated with extract use. Provisional threshold levels of safety and effectiveness were established, and extracts were sorted according to whether they met the thresholds. RESULTS: In the Adverse Event Reporting System, there were 178 adverse event reports, including 13 deaths, associated with allergen extract use over 23 years. No single group of extracts predominated. Among 1269 allergen extracts reviewed, there were 480 for which use in the diagnosis and treatment of allergic disease were addressed in the literature, 207 for which only diagnostic use was addressed, 565 for which minimal or no supportive literature was identified, and 17 for which potential safety concerns were found. CONCLUSIONS: When used according to professional guidelines, almost all nonstandardized allergen extracts for diagnosis and therapy appear to be safe. Provisional thresholds of effectiveness were met by 54% of extracts reviewed.
Jay E Slater; Sandra L Menzies; Jennifer Bridgewater; Alexis Mosquera; Craig E Zinderman; Alan C Ou; Diane Maloney; Catherine M Cook; Ronald L Rabin
Related Documents :
22935949 - Analysis of 16 years of homicides and suicides involving the use of weapons recorded at...
10958259 - Acute and longer-term effects of risperidone in a case of first-episode catatonic schiz...
22315679 - Toothbrush contamination: a review of the literature.
22217379 - Intestinal obstruction by giant meckel's diverticulum. case report.
19789499 - Acute psychosis and gender.
14590999 - Neuropsychological assessment and malingering: a critical review of past and present st...
24854779 - Reporting sexual assault in the military: who reports and why most servicewomen don't.
2914549 - Isolated granulomatous gastritis in an adolescent.
7826119 - Toledo type brachyolmia.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-15
Journal Detail:
Title:  The Journal of allergy and clinical immunology     Volume:  -     ISSN:  1097-6825     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1275002     Medline TA:  J Allergy Clin Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Division of Bacterial Parasitic and Allergenic Products, Office of Vaccines Research and Review, Rockville, Md.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Modelling bovine babesiosis: A tool to simulate scenarios for pathogen spread and to test control me...
Next Document:  Efficacy of a comprehensive rehabilitation programme combined with pharmacological treatment in redu...